Real-time PCR-based analysis of the human bile micrornaome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Shigehara, Kengo ^a   Yokomuro, Shigeki ^a   Ishibashi, Osamu ^a   Mizuguchi, Yoshiaki ^a   Arima, Yasuo ^a   Kawahigashi, Yutaka ^a   Kanda, Tomohiro ^a   Akagi, Ichiro ^a   Tajiri, Takashi ^a   Yoshida, Hiroshi ^a   Takizawa, Toshihiro ^a   Uchida, Eiji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 9; UNCLASSIFIED DRUG; MIRN9 MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CLINICAL ARTICLE; COMMON BILE DUCT STONE; CONTROLLED STUDY; CYTOSKELETON; DIAGNOSTIC ACCURACY; DOWN REGULATION; ENDOSCOPIC ECHOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; RNA STABILITY; SENSITIVITY AND SPECIFICITY; UPREGULATION; BILE; BILIARY TRACT TUMOR; DNA MICROARRAY; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BILE; BILIARY TRACT NEOPLASMS; CHOLEDOCHOLITHIASIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 80051736673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023584     Document Type: Article

References (61)

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM, (1999) Biliary tract cancers. N Engl J Med 341: 1368-1378.
2. Tajiri T, Yoshida H, Mamada Y, Taniai N, Yokomuro S, et al. (2008) Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice. World J Gastroenterol 14: 3000-3005.
3. Olnes MJ, Erlich R, (2004) A review and update on cholangiocarcinoma. Oncology 66: 167-179.
4. Lazaridis KN, Gores GJ, (2005) Cholangiocarcinoma. Gastroenterology 128: 1655-1667.
5. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 (Suppl 6): VI1-9.
6. Aljiffry M, Walsh MJ, Molinari M, (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 15: 4240-4262.
7. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M, (2004) Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 99: 1069-1073.
8. Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, et al. (2006) Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24: 1152-1160.
9. Isomoto H, Kobayashi S, Werneburg NW, Bronk SF, Guicciardi ME, et al. (2005) Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42: 1329-1338.
10. Okaro AC, Deery AR, Hutchins RR, Davidson BR, (2001) The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium. J Clin Pathol 54: 927-932.
11. Endo K, Yoon BI, Pairojkul C, Demetris AJ, Sirica AE, (2002) ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology 36: 439-450.
12. Kuroki T, Tajima Y, Kanematsu T, (2005) Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. J Hepatobiliary Pancreat Surg 12: 463-466.
13. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
14. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, et al. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545.
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
16. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490.
17. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
18. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
19. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, et al. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14: 27-41.
20. Melkonyan HS, Feaver WJ, Meyer E, Scheinker V, Shekhtman EM, et al. (2008) Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci 1137: 73-81.
21. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
22. Esteller A, (2008) Physiology of bile secretion. World J Gastroenterol 14: 5641-5649.
23. Mishima T, Takizawa T, Luo SS, Ishibashi O, Kawahigashi Y, et al. (2008) MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction 136: 811-822.
24. Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, et al. (2010) Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol 299: G990-999.
25. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, et al. (2002) Molecular Biology of the Cell New York Garland Science.
26. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R, (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24.
27. Fischer HP, Altmannsberger M, Weber K, Osborn M, (1987) Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects. Am J Pathol 127: 530-537.
28. Van Eyken P, Sciot R, Callea F, Van der Steen K, Moerman P, et al. (1988) The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 8: 1586-1595.
29. Raj V, Lichtenstein DR, (2000) Hepatobiliary manifestations of inflammatory bowel disease. Am J Surg Pathol 24: 870-876.
30. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, et al. (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49: 1595-1601.
31. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, et al. (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29: 5724-5728.
32. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
33. Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, et al. (2010) MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol 27: 654-660.
34. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
35. Guo LM, Pu Y, Han Z, Liu T, Li YX, et al. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276: 5537-5546.
36. Tryndyak VP, Ross SA, Beland FA, Pogribny IP, (2009) Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 48: 479-487.
37. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, et al. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
38. Tsui NB, Ng EK, Lo YM, (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48: 1647-1653.
39. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
40. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
41. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
42. Taylor DD, Gercel-Taylor C, (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21.
43. Rosch T, Meining A, Fruhmorgen S, Zillinger C, Schusdziarra V, et al. (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55: 870-876.
44. Varghese JC, Farrell MA, Courtney G, Osborne H, Murray FE, et al. (1999) A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease. Clin Radiol 54: 513-520.
45. Garrow D, Miller S, Sinha D, Conway J, Hoffman BJ, et al. (2007) Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol 5: 616-623.
46. Tamada K, Ueno N, Tomiyama T, Oohashi A, Wada S, et al. (1998) Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc 47: 341-349.
47. Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, et al. (2002) Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 56: 372-379.
48. Menzel J, Domschke W, (2000) Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol 95: 605-616.
49. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, et al. (2001) Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol 54: 449-455.
50. Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB, (1995) Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol 90: 722-726.
51. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, et al. (1999) Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31: 712-717.
52. Jailwala J, Fogel EL, Sherman S, Gottlieb K, Flueckiger J, et al. (2000) Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 51: 383-390.
53. Mansfield JC, Griffin SM, Wadehra V, Matthewson K, (1997) A prospective evaluation of cytology from biliary strictures. Gut 40: 671-677.
54. Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, et al. (1995) Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 42: 565-572.
55. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B, (1995) Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 42: 520-526.
56. Kubota Y, Yamaguchi T, Tani K, Takaoka M, Fujimura K, et al. (1993) Anatomical variation of pancreatobiliary ducts in biliary stone diseases. Abdom Imaging 18: 145-149.
57. Rosch T, Hofrichter K, Frimberger E, Meining A, Born P, et al. (2004) ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 60: 390-396.
58. Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, et al. (2004) Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2: 209-213.
59. Fritscher-Ravens A, Broering DC, Sriram PV, Topalidis T, Jaeckle S, et al. (2000) EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc 52: 534-540.
60. Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, et al. (2004) EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 99: 45-51.
61. Byrne MF, Gerke H, Mitchell RM, Stiffler HL, McGrath K, et al. (2004) Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy 36: 715-719.